Peptide Libraries TRIZ Cases

Polymer coatings secure metal nanoparticles on substrates, resolving reproducibility issues in distance-dependent plasmonic enhancement.

A one-pot library binding assay identifies agents that bind to exo-sites of proteins.

A ciliate host cell system produces monoclonal antibodies with fucose-free N-glycan structures.

Framework residue substitutions improve CH2 domain stability and solubility while preserving FcRn binding characteristics.

Modifying immunoglobulin structural loop regions introduces new antigen binding sites without disrupting protein folding.

DNA mutagenesis creates mutant proteins inactive at physiological temperatures but active at lower aberrant conditions, reducing systemic side effects.

A modular cloning system uses type IIs restriction endonucleases to assemble multiple DNA fragments in a single step.

Segmenting the alpha chain into a fixed TRAV12-2 framework resolves the contradiction between library diversity and functional reliability.

Machine learning models predict activation domain locations across species, resolving coarse resolution limits in experimental screening.

Adding bacteriophage lambda Gam protein prevents mRNA degradation, extending reaction longevity and improving protein selection efficiency.

A lysine-based linking reagent conjugates to a glutamine residue within a myc peptide tag on antibody fragments.

Orthogonal peptide linkers form irreversible isopeptide bonds, resolving synthesis errors and instability in complex protein assembly.

Serum Epitope Repertoire Analysis profiles antibody repertoires using bacterial display peptide libraries, resolving low sensitivity in acute phase diagnosis.

Combinatorial oligopeptide derivatives resolve toxicity and resistance trade-offs by forming supramolecular ensembles that treat viral infections at all stages.

Reusable electrodes in assay cartridges enable biochemical signal detection while reducing device complexity for point-of-care diagnostics.

Proteome array screening selects monospecific antibodies early, reducing production time and cost while maintaining high specificity.

Chemical modification of cysteine residues in ribosome display complexes maintains mRNA-polypeptide linkage.

Screening amphiphilic peptides with alternating leucine and lysine sequences to identify strong binding agents.

Mutations in Stefin A scaffolds create multiple insertion sites, increasing interaction surface area and binding affinity while preventing peptide truncation.

Conditionally active receptor agonists comprising separate polypeptide components that interact to form active complexes.

A rapid screening method identifies translational fusion partners that induce recombinant protein secretion.

Protease-specific cleavage of the linker activates cytokines locally at tumor sites, reducing systemic toxicity while maintaining antitumor efficacy.

Three-dimensional scaffolds in a cartridge microfluidic system preserve cell structure, preventing the loss of function seen on flat surfaces.

Segmenting pIX functions resolves the conflict between virion stability and multivalent display capability, enabling isolation of weak-binding clones.

In vitro translation incorporates reactive unnatural amino acids to enable high-throughput dual-labeling, resolving low sample preparation throughput.

Segmented variable and constant regions allow unrestricted exchange of TCR sub-domains, resolving synthesis inefficiency and throughput bottlenecks.

Replacing cysteine residues with serine or alanine stabilizes scFv folding under reducing conditions, enabling efficient intrabody production.

Unstructured recombinant polymers extend serum half-life and solubility of modified proteins through increased hydrodynamic radius.

Modified polypeptide scaffolds replace unstable residues to improve alkaline stability and reduce purification complexity.

Trinucleotide mutagenesis biases HCDR3 sequences toward natural human distributions, reducing non-functional binders and easing screening.

A polypeptide with an inhibiting domain suppresses antigen binding until protease cleavage activates the carrier moiety.

VpreB and lambda5 sequences form surrogate light chains that pair with antibody heavy chains to create diverse binding specificities.

A DNA barcode and primer group enable rapid fluorescent PCR amplification for identifying high-quality Floccularia luteovirens strains.

Pre-assembled fluorophore structures in synthetic GYRAPT aptamers eliminate complex protein folding steps, improving fluorescence signal reliability.

CH3 domain mutations enable pH-dependent FcRn recycling, extending half-life while reducing molecular weight and non-specific binding.

Modifying non-conserved FHA sequences creates antibody-like binders, reducing production time and cost compared to traditional methods.

Optimized HC-CDR3 library design restricts diversity to specific loop regions for focused phage selection.

Defined di- and tripeptides terminating in arginine replace animal-derived peptones to eliminate viral contamination risks while maintaining high productivity.

Cysteine-labeled protein probes enable high-throughput screening of unbound analytes via site-specific fluorophore attachment.

Segmented modules handle cell concentration and transformation, resolving low automation compatibility during nucleic acid editing.

Amino acids with side chains forming intramolecular hydrogen bonds mask proton donors to enhance membrane permeability.

Pre-evaluated synthetic sequences build a stable feline antibody library that resolves the contradiction between species compatibility and efficacy retention.

Measuring microRNA expression levels in colon cancer tissue samples to identify specific molecular markers.

Capture reagents immobilize fertility proteins on chips for direct quantitative analysis of seminal plasma samples.

Framework assembly constructs humanized antibodies using germline libraries and phage display selection.

A hydrophilic microfluidic chip uses surface tension to fill hybridization chambers automatically.

A nanocrescent SERS probe detects proteolytic activity via peptide cleavage.

Modified shark IgNAR-derived binding domains immobilized on substrates via linkers enhance analyte capture capacity.